Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/127646
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amat Tusón, Mercedes | - |
dc.contributor.author | Semak, Vladislav | - |
dc.contributor.author | Escolano Mirón, Carmen | - |
dc.contributor.author | Molins i Grau, Elies | - |
dc.contributor.author | Bosch Cartes, Joan | - |
dc.date.accessioned | 2019-01-28T10:04:58Z | - |
dc.date.available | 2019-01-28T10:04:58Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1477-0520 | - |
dc.identifier.uri | https://hdl.handle.net/2445/127646 | - |
dc.description.abstract | A practical enantioselective protecting group-free four-step route to the key quinolizidinone 6 from phenylglycinol-derived bicyclic lactam 1 is reported. The Grignard addition reaction to 6 takes place stereoselectively to give 1-ethyl-4-substituted quinolizidines 4-epi-207I and 7-9. Following a similar synthetic sequence, 9a-epi-6 is also accessed. However, the addition of Grignard reagents to 9a-epi-6 proceeds in a non-stereoselective manner. In order to gain insight into the different stereochemical outcome in the two series, theoretical calculations on the iminium salts A and B have been performed. The study concludes that the addition of the hydride, which is the step that determines the configuration of the final products, occurs in a stereoelectronic controlled manner. The theoretical study is in agreement with the experimental results. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Royal Society of Chemistry | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1039/C2OB25392E | - |
dc.relation.ispartof | Organic & Biomolecular Chemistry, 2012, vol. 10, p. 6866-6875 | - |
dc.relation.uri | https://doi.org/10.1039/C2OB25392E | - |
dc.rights | (c) Amat Tusón, Mercedes et al., 2012 | - |
dc.source | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | - |
dc.subject.classification | Alcaloides | - |
dc.subject.classification | Síntesi asimètrica | - |
dc.subject.classification | Síntesi orgànica | - |
dc.subject.classification | Compostos bioactius | - |
dc.subject.other | Alkaloids | - |
dc.subject.other | Asymmetric synthesis | - |
dc.subject.other | Organic synthesis | - |
dc.subject.other | Bioactive compounds | - |
dc.title | Enantioselective protecting group-free synthesis of 1-S-ethyl-4-substituted quinolizidines | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 613956 | - |
dc.date.updated | 2019-01-28T10:04:58Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) Articles publicats en revistes (Institut de Biomedicina (IBUB)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
613956.pdf | 423.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.